The prize for innovation and utilization
The prize recognizes one or more researchers/research students who have distinguished themselves through outstanding utilization of research results that have led to innovation. Anyone can nominate one or more candidates.
The 2023 Prize for Innovation and Utilization
Karolinska Institutet has decided to award Johan Hartman and Mattias Rantalainen.
Johan Hartman is a professor of tumour pathology at the Department of Oncology-Pathology and Mattias Rantalainen is an associate professor at the Department of Medical Epidemiology and Biostatistics. Both are co-founders of Stratipath, a private spin-off that aims to improve the diagnostic of cancer patients using AI.
They are rewarded for improving cancer diagnostics with innovative research and inspiring working methods,
The prize committee's justification:
"Johan Hartman and Mattias Rantalainen have a long track-record of innovative research within tumor pathology, machine learning and statistical modelling, with the aim to improve cancer diagnostics. They have succeeded in developing and commercializing a method for artificial intelligence-based analysis of microscopy images, which is now in clinical use for determining the risk for relapse in cancer after surgery. The product has a large potential in precision diagnostics in other diseases. Hartman and Rantalainen continue to combine academic research and entrepreneurship in an exemplary and inspiring manner and fulfill all criteria for recipients of the Prize for Innovation and Utilization."
Starting in 2022 Karolinska Institutet awarded a prize for innovation and utilization.
The prize will be awarded to one or more active researchers/research students (employed, adjunct or affiliated with KI).
If an individual cannot be considered to be behind the innovation on their own, a maximum of three people can share the prize.
Anyone can nominate one or more candidates. Self-nominations are accepted.